Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Dysplasia 1Papillomavirus Infections 1Carcinoma in Situ 1

Interventions

pembrolizumab 304Carboplatin 157Nivolumab 154Cisplatin 140Cyclophosphamide 131Paclitaxel 127Magnetic Resonance Spectroscopy 99Specimen Handling 96Radiotherapy 91Gemcitabine 87Dexamethasone 83Biopsy 81Ipilimumab 78Docetaxel 76Doxorubicin 75Rituximab 69Etoposide 67atezolizumab 61Radiation 60durvalumab 60Lenalidomide 59Pemetrexed 59Taxes 57Prednisone 55Bevacizumab 54fludarabine 54olaparib 53Vincristine 50Cytarabine 49Fluorouracil 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Codeine × 1 year × Clear all
NCT02858310 2026-03-09

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
224 enrolled 15 charts
Gynecologic

Carcinoma in Situ, Uterine Cervical Dysplasia, Vulvar Diseases, Vulvar Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡